Supernus Pharmaceuticals

Supernus Pharmaceuticals (NASDAQ:SUPN) Reports 41% Shareholder Loss Amidst Five-Year Earnings Decline

For a lot of people, the main goal of investing is to make more money than what the entire market achieves. However, even someone who’s really good at picking stocks will only have some of their choices turn out successful. Right now, some people who invested in Supernus Pharmaceuticals, Inc. (NASDAQ:SUPN) might be questioning their […]

Supernus Pharmaceuticals (NASDAQ:SUPN) Reports 41% Shareholder Loss Amidst Five-Year Earnings Decline Read More ยป